Guowen Wang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 8
- Oncology top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 15
- Circular RNAs in diseases 6
- Ubiquitin and proteasome pathways 5
-
- Ferroptosis and cancer prognosis 10
- Sarcoma Diagnosis and Treatment 7
-
- interferon and immune responses 5
- Co-authors
- Shunbin XiongTianyang MuXuejun JiangJilong YangXiaoling DuXiuxin HanKexin ChenChuankui Li
- Journals
- Frontiers in Immunology (6 papers)BMC Genomics (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaRussiaUnited States
In The Last Decade
Guowen Wang
87 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 471
- Oncology 399
- Molecular Biology 932
- Pulmonary and Respiratory Medicine 374
- Immunology 169
Countries citing papers authored by Guowen Wang
This map shows the geographic impact of Guowen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guowen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guowen Wang more than expected).
Fields of papers citing papers by Guowen Wang
This network shows the impact of papers produced by Guowen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guowen Wang. The network helps show where Guowen Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guowen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 13 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 66 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 8 | |
| 12 | 2019 | 19 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 20 | |
| 15 | Epidural fibrosis post laminectomy is the unappreciated cause of spinal cord compression post chronic spinal cord injury | 2017 | 3 |
| 16 | 2015 | 48 | |
| 17 | 2013 | 20 | |
| 18 | 2012 | 3 | |
| 19 | 2011 | 1 | |
| 20 | Using microarrays to differentiate chondrosarcomas | 2007 | 1 |
About Guowen Wang
Guowen Wang is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (15 papers), Ferroptosis and cancer prognosis (10 papers), MicroRNA in disease regulation (8 papers), Sarcoma Diagnosis and Treatment (7 papers), Circular RNAs in diseases (6 papers), interferon and immune responses (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (471 citations), Oncology (399 citations), Molecular Biology (932 citations), Pulmonary and Respiratory Medicine (374 citations) and Immunology (169 citations). Guowen Wang has collaborated with scholars based in China, Russia and United States. Frequent co-authors include Shunbin Xiong, Tianyang Mu, Xuejun Jiang, Jilong Yang, Xiaoling Du, Xiuxin Han, Kexin Chen, Chuankui Li, Wenxia Zhou and Zuyi Wang. Their work appears in journals such as Frontiers in Immunology, BMC Genomics, Journal of Clinical Oncology, Aging and Theriogenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.